At the second biopsy, wherein another biopsy was performed after the first-line treatment for the 67 CE-positive patients, CD138 cells disappeared in 21 patients (defined as “CE first-line group”), and the remaining 46 patients were subjected to second-line treatment (defined as “CE second-line group”). The gene discussed is SDC1; the disease is cholesteryl ester measurement.